首页> 外文OA文献 >How Pure is Pure? Metal Complexation Studies Directed Towards Pharmaceutical Drug Purification
【2h】

How Pure is Pure? Metal Complexation Studies Directed Towards Pharmaceutical Drug Purification

机译:纯净是多少?金属络合研究针对药物纯化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Catalytic processes play critical roles in the modern-day industrial syntheses of many commonplace materials such as plastics, fuel production, electronics, and pharmaceuticals. Transition metal catalysts may become homogeneously embedded within solid nanomaterials during their synthetic scheme, which can result in deleterious effects on both the construction and durability of the material as well as its intended functionality.Traditional purification methods of these materials rely upon harsh reaction conditions that may either affect or allow for specific functionalities. Arylazothioformamide (ATF) ligands have proven to be a mild alternative for their ability to chelate these solid transition metal catalysts.This work will describe the synthetic steps towards developing a versatile library of ATF ligands, the characterization of those already synthesized, and initial chelation studies directed towards the purification of pharmaceutical drugs which employ catalytic processes in their production.
机译:在许多常见材料的现代工业合成中,例如塑料,燃料生产,电子和制药,催化过程起着至关重要的作用。过渡金属催化剂在合成过程中可能会均匀地嵌入固体纳米材料中,这可能对材料的结构和耐用性以及预期的功能性产生有害影响。这些材料的传统提纯方法依赖于苛刻的反应条件。影响或允许特定功能。事实证明,芳基偶氮硫甲酰胺(ATF)配体可以螯合这些固体过渡金属催化剂,是一种温和的替代品。这项工作将描述开发通用ATF配体库的合成步骤,已经合成的那些的表征以及初步的螯合研究旨在纯化在生产中采用催化过程的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号